###begin article-title 0
###xml 105 109 105 109 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SDHA</italic>
###xml 22 27 <span type="species:ncbi:9606">human</span>
Sequence variation in human succinate dehydrogenase genes: evidence for long-term balancing selection on SDHA
###end article-title 0
###begin p 1
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
###end p 1
###begin title 2
Background
###end title 2
###begin p 3
###xml 369 374 369 374 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SDHA </italic>
###xml 419 424 419 424 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SDHA </italic>
###xml 595 600 595 600 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SDHA </italic>
###xml 730 734 730 734 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SDHB</italic>
###xml 736 740 736 740 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SDHC</italic>
###xml 746 750 746 750 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SDHD</italic>
Balancing selection operating for long evolutionary periods at a locus is characterized by the maintenance of distinct alleles because of a heterozygote or rare-allele advantage. The loci under balancing selection are distinguished by their unusually high polymorphism levels. In this report, we provide statistical and comparative genetic evidence suggesting that the SDHA gene is under long-term balancing selection. SDHA encodes the major catalytical subunit (flavoprotein, Fp) of the succinate dehydrogenase enzyme complex (SDH; mitochondrial complex II). The inhibition of Fp by homozygous SDHA mutations or by 3-nitropropionic acid poisoning causes central nervous system pathologies. In contrast, heterozygous mutations in SDHB, SDHC, and SDHD, the other SDH subunit genes, cause hereditary paraganglioma (PGL) tumors, which show constitutive activation of pathways induced by oxygen deprivation (hypoxia).
###end p 3
###begin title 4
Results
###end title 4
###begin p 5
###xml 129 134 129 134 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SDHA </italic>
###xml 222 227 222 227 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SDHA </italic>
###xml 324 329 324 329 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SDHA </italic>
###xml 465 470 465 470 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SDHA </italic>
###xml 557 562 557 562 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SDHA </italic>
###xml 830 832 829 831 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D </italic>
###xml 848 853 847 852 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SDHA </italic>
###xml 154 165 <span type="species:ncbi:9598">chimpanzees</span>
###xml 216 221 <span type="species:ncbi:9606">human</span>
###xml 241 251 <span type="species:ncbi:9598">chimpanzee</span>
We sequenced the four SDH subunit genes (10.8 kb) in 24 African American and 24 European American samples. We also sequenced the SDHA gene (2.8 kb) in 18 chimpanzees. Increased nucleotide diversity distinguished the human SDHA gene from its chimpanzee ortholog and from the PGL genes. Sequence analysis uncovered two common SDHA missense variants and refuted the previous suggestions that these variants originate from different genetic loci. Two highly dissimilar SDHA haplotype clusters were present in intermediate frequencies in both racial groups. The SDHA variation pattern showed statistically significant deviations from neutrality by the Tajima, Fu and Li, Hudson-Kreitman-Aguade, and Depaulis haplotype number tests. Empirically, the elevated values of the nucleotide diversity (% pi = 0.231) and the Tajima statistics (D = 1.954) in the SDHA gene were comparable with the most outstanding cases for balancing selection in the African American population.
###end p 5
###begin title 6
Conclusion
###end title 6
###begin p 7
###xml 4 9 4 9 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SDHA </italic>
###xml 65 70 65 70 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SDHA </italic>
###xml 119 124 <span type="species:ncbi:9606">human</span>
The SDHA gene has a strong signature of balancing selection. The SDHA variants that have increased in frequency during human evolution might, by influencing the regulation of cellular oxygen homeostasis, confer protection against certain environmental toxins or pathogens that are prevalent in Africa.
###end p 7
###begin title 8
Background
###end title 8
###begin p 9
###xml 182 183 182 183 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 248 252 248 252 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SDHA</italic>
###xml 254 258 254 258 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SDHB</italic>
###xml 260 264 260 264 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SDHC</italic>
###xml 270 274 270 274 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SDHD</italic>
###xml 276 281 276 281 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SDHA </italic>
###xml 309 314 309 314 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SDHB </italic>
###xml 456 461 456 461 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SDHC </italic>
###xml 489 494 489 494 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SDHD </italic>
###xml 620 636 620 636 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SDHA, SDHB, SDHC</italic>
###xml 642 647 642 647 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SDHD </italic>
###xml 778 779 778 779 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 780 781 780 781 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
Succinate dehydrogenase (SDH; mitochondrial complex II) is an essential enzyme complex that has dual roles in the Krebs cycle and the electron transport chain (ETC) in mitochondria [1]. SDH is composed of four subunits encoded by the nuclear genes SDHA, SDHB, SDHC, and SDHD. SDHA at chromosome band 5p15 and SDHB at chromosome band 1p35 encode the two catalytical hydrophilic subunits flavoprotein (Fp; 70 kDa) and iron-sulfur (Ip; 35 kDa), respectively. SDHC at chromosome band 1q23 and SDHD at chromosome 11q23 encode the two membrane-spanning hydrophobic subunits, cybL (15 kDa) and cybS (12 kDa), respectively. The SDHA, SDHB, SDHC, and SDHD gene products are encoded by 15, 8, 6, and 4 exons, which span genomic distances of ~38 kb, 35 kb, 50 kb. and 10 kb, respectively [2,3].
###end p 9
###begin p 10
###xml 26 31 26 31 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SDHD </italic>
###xml 217 218 217 218 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
###xml 246 250 246 250 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SDHB</italic>
###xml 252 256 252 256 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SDHC</italic>
###xml 262 267 262 267 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SDHD </italic>
###xml 378 379 378 379 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 380 382 380 382 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B10">10</xref>
###xml 428 429 428 429 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
###xml 478 480 478 480 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
###xml 497 499 497 499 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 524 526 524 526 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 587 589 587 589 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
The identification of the SDHD subunit gene as the hereditary paraganglioma type 1 locus (PGL1) has uncovered unexpected links between SDH and tumor susceptibility, and highlighted the role of mitochondria in cancer [4]. Since then, mutations in SDHB, SDHC, and SDHD subunit genes (PGL genes) have been established as an important cause of sporadic and familial paragangliomas [5-10]. The paraganglia specificity of PGL tumors [4] and data from global gene-expression analysis [11], cell biology [12], animal-model studies [13], and gene-environment interaction and population genetics [14] support the hypothesis that constitutive hypoxic stimulation underlies the pathogenesis of PGL.
###end p 10
###begin p 11
###xml 185 187 185 187 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 404 406 404 406 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 597 599 597 599 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 709 711 709 711 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 864 866 864 866 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 383 393 <span type="species:ncbi:128810|species:ncbi:4547">sugarcanes</span>
The role of SDH in disease pathogenesis has been implicated independently through a series of studies on a widely distributed plant and fungal neurotoxin, 3-nitropropionic acid (3-NPA)[15]. Acute food poisoning with 3-NPA, which can lead to central nervous system defects with lifelong disability and to mortality in ~10% of the cases, have been associated with consumption of moldy sugarcanes in China [16]. The neurodegeneration induced by 3-NPA poisoning often involves the basal ganglia, hippocampus, spinal tracts, and peripheral nerves, and the symptoms mimic those of Huntington's disease [17]. 3-NPA irreversibly inhibits SDH, owing to the similarity of the chemical structures of 3-NPA to succinate [18]. It has been suggested that 3-NPA may form a covalent adduct with an arginine residue at amino acid position 345 in the active site of the Fp subunit [19].
###end p 11
###begin p 12
###xml 57 62 57 62 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SDHA </italic>
###xml 131 136 131 136 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SDHA </italic>
###xml 171 173 171 173 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 280 285 280 285 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SDHA </italic>
###xml 485 490 485 490 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SDHA </italic>
###xml 494 499 494 499 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SDHB </italic>
###xml 660 662 660 662 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
###xml 802 804 802 804 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 805 807 805 807 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B23">23</xref>
###xml 1077 1082 1077 1082 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SDHA </italic>
###xml 1136 1141 1136 1141 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SDHA </italic>
###xml 1239 1244 1239 1244 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SDHA </italic>
###xml 1290 1295 1290 1295 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SDHA </italic>
###xml 1391 1393 1391 1393 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 1418 1420 1418 1420 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B25">25</xref>
###xml 1458 1463 1458 1463 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SDHA </italic>
###xml 1674 1679 1674 1679 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SDHA </italic>
###xml 1700 1702 1700 1702 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B25">25</xref>
###xml 1739 1744 1739 1744 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SDHA </italic>
###xml 1892 1897 1892 1897 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SDHA </italic>
###xml 1317 1322 <span type="species:ncbi:9606">human</span>
Surprisingly, mutations in the major catalytical subunit SDHA have yet to be associated with PGL. Although homozygous mutations in SDHA have been found in Leigh syndrome [20], a severe neurodegenerative disorder of childhood, and with neuromusculopathies, no genetic link between SDHA and paraganglioma susceptibility has ever been established. Current biochemical knowledge on SDH provides very few clues for the phenotypic dichotomy arising from the germline subunit gene mutations. SDHA and SDHB subunits encode the two physically-interacting catalytical subunits, so it is surprising that their mutations would have such different phenotypic consequences [21]. Recently, after identifying cDNA sequences encoding a missense Fp variant containing the Y629F and V657I polymorphisms, Tomitsuka et al [22,23] proposed that distinct genetic loci encode two Fp variants, namely type I and type II. They reached this conclusion after observing tissue-specific and cell line-specific differential expression of the cDNA variants and PCR amplification from genomic DNA of processed SDHA gene fragments that lacked introns (i.e, a functional SDHA retrogene). However, the genomic location of the retrogene that was proposed to encode the second SDHA gene could not be determined. A retrogene for SDHA is not present in the human genome, according to the March 2006 assembly in The UCSC database. [24] Finally, Briere et al [25] showed the presence of the missense SDHA variants in several different cell types and assumed that these variants originate from two different genes, although they provided no experimental or bioinformatic evidence for the genomic presence of a second SDHA locus. Briere et al [25] suggested that the presence of two SDHA genes in paraganglia prevents tumorigenesis. If Fp were encoded by two different loci, this would indeed have provided a simple explanation for why SDHA mutations would not be associated with PGL susceptibility.
###end p 12
###begin p 13
###xml 743 748 743 748 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SDHA </italic>
An alternative approach to gain insights into gene function involves analysis of sequence variation in the population. To date, no study has systematically addressed the variation patterns in the SDH subunit genes in normal subjects from different racial or ethnic groups. To gain further insights into the multiple roles of SDH in disease predisposition and to help to integrate the seemingly disparate phenotypic consequences of SDH subunit defects, we examined sequence variation in the complete coding and partial flanking intronic sequences of the four SDH subunit genes in 24 samples from an African American population and 24 samples from a white population. These analyses uncovered an unexpected degree of nucleotide diversity in the SDHA gene.
###end p 13
###begin title 14
Results
###end title 14
###begin title 15
Sequence variants in the SDH subunit genes
###end title 15
###begin p 16
###xml 308 309 308 309 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
###xml 478 483 478 483 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SDHA </italic>
###xml 494 498 494 498 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SDHC</italic>
###xml 665 666 665 666 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S1">1</xref>
###xml 725 727 725 727 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B26">26</xref>
###xml 730 735 730 735 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SDHA </italic>
###xml 867 869 867 869 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B27">27</xref>
###xml 937 938 937 938 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1</xref>
Using PCR, each coding exon and the flanking introns of the four SDH subunit genes in 24 European American and 24 African American samples were amplified, and were then sequenced. In total, 3828 coding and 7013 non-coding nucleotides were sequenced for each sample, and 52 polymorphisms were detected (Table 1). The heterozygous frequencies of all variants were consistent with Hardy-Weinberg expectations (p > 0.01) in both sets of samples. Except for two non-coding indels in SDHA and one in SDHC, all variants were single nucleotide polymorphisms (SNPs) involving base replacements. A full list of the identified sequence variants is provided in Additional File 1 and has also been submitted to the SDH mutation database [26]. SDHA variant density was 2.6-fold and 2.3-fold higher in the coding and non-coding regions, respectively, than the average of 106 genes [27]. The minor allele frequencies of all variants are shown in Figure 1.
###end p 16
###begin title 17
Nucleotide diversity in SDH subunit genes
###end title 17
###begin p 18
###xml 112 114 107 109 <sub xmlns:xlink="http://www.w3.org/1999/xlink">s </sub>
###xml 121 122 116 117 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T2">2</xref>
###xml 284 289 279 284 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SDHB </italic>
###xml 303 308 297 302 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SDHC </italic>
###xml 326 331 319 324 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SDHD </italic>
###xml 390 395 382 387 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SDHA </italic>
###xml 543 545 533 535 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B28">28</xref>
###xml 557 559 543 545 <sub xmlns:xlink="http://www.w3.org/1999/xlink">s </sub>
###xml 650 655 635 640 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SDHC </italic>
###xml 659 663 644 648 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SDHD</italic>
###xml 779 781 759 761 <sub xmlns:xlink="http://www.w3.org/1999/xlink">s </sub>
###xml 789 794 769 774 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SDHA </italic>
###xml 882 884 858 860 <sub xmlns:xlink="http://www.w3.org/1999/xlink">s </sub>
###xml 920 925 896 901 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SDHB </italic>
###xml 1051 1053 1023 1025 <sub xmlns:xlink="http://www.w3.org/1999/xlink">s </sub>
###xml 1093 1095 1064 1066 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B28">28</xref>
###xml 1214 1217 1185 1188 <sub xmlns:xlink="http://www.w3.org/1999/xlink">ST </sub>
###xml 1340 1344 1311 1315 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SDHA</italic>
###xml 1346 1350 1317 1321 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SDHC</italic>
###xml 1356 1361 1327 1332 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SDHD </italic>
###xml 1384 1389 1355 1360 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SDHB </italic>
###xml 1401 1402 1372 1373 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T2">2</xref>
###xml 1474 1479 1445 1450 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SDHB </italic>
###xml 1205 1211 <span type="species:ncbi:9606">humans</span>
We calculated the nucleotide diversity in SDH subunit genes using the population genetic parameters pi and thetas (Table 2). As expected, all diversity indices were higher in the African American samples. The nucleotide diversity (%) in the total sample set was low at the PGL genes: SDHB (pi = 0.008), SDHC (pi = 0.065), and SDHD (pi = 0.044). In contrast, the nucleotide diversity of the SDHA gene (pi = 0.199%) was 5.1-fold higher than the average of the PGL genes and 3.4-fold higher than the average (pi = 0.058%) of 292 autosomal genes [28]. The thetas and pi estimates of nucleotide diversities were similar for the membrane-spanning subunits SDHC and SDHD, but differed substantially for the two catalytic subunits. Whereas the pi estimate was ~1.6-fold higher than thetas for the SDHA gene, consistent with the enrichment of alleles with intermediate frequencies, the thetas estimate was ~4-fold higher for the SDHB gene, indicating the very low frequency of the allelic variants. For comparison, 90% of the genes in a recent survey had thetas estimates higher than the pi estimates [28], indicating an abundance of rare alleles, which is thought to be a result of recent population expansion in humans. FST statistics provided statistically significant evidence of population differentiation between the two racial groups for the SDHA, SDHC, and SDHD genes, but not for the SDHB gene (Table 2). This was attributable to the very low frequencies and the absence of SDHB allelic variants in the African American and European American samples, respectively.
###end p 18
###begin title 19
###xml 39 44 39 44 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SDHA </italic>
###xml 18 23 <span type="species:ncbi:9606">human</span>
###xml 28 38 <span type="species:ncbi:9598">chimpanzee</span>
Comparison of the human and chimpanzee SDHA genes for sequence diversity
###end title 19
###begin p 20
###xml 76 81 76 81 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SDHA </italic>
###xml 315 316 315 316 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
###xml 432 437 432 437 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SDHA </italic>
###xml 460 461 460 461 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S2">2</xref>
###xml 547 552 547 552 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SDHA </italic>
###xml 659 661 659 661 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B29">29</xref>
###xml 679 684 679 684 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SDHA </italic>
###xml 853 854 852 853 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T3">3</xref>
###xml 875 877 870 872 <sub xmlns:xlink="http://www.w3.org/1999/xlink">s </sub>
###xml 1040 1045 1034 1039 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SDHA </italic>
###xml 65 75 <span type="species:ncbi:9598">chimpanzee</span>
###xml 99 104 <span type="species:ncbi:9606">human</span>
###xml 154 164 <span type="species:ncbi:9598">chimpanzee</span>
###xml 411 416 <span type="species:ncbi:9606">human</span>
###xml 421 431 <span type="species:ncbi:9598">chimpanzee</span>
###xml 637 642 <span type="species:ncbi:9606">human</span>
###xml 647 657 <span type="species:ncbi:9598">chimpanzee</span>
###xml 668 678 <span type="species:ncbi:9598">chimpanzee</span>
###xml 742 747 <span type="species:ncbi:9606">human</span>
###xml 835 840 <span type="species:ncbi:9606">human</span>
###xml 940 950 <span type="species:ncbi:9598">chimpanzee</span>
###xml 1119 1124 <span type="species:ncbi:9606">human</span>
To test whether high nucleotide diversity also characterizes the chimpanzee SDHA gene, we used the human PCR primers to amplify and sequence 18 unrelated chimpanzee samples. We obtained high-quality sequences for exons 3-6, 8, 12, 13, and 15, which together comprise a total genomic sequence size of 2832 bp (Table 1). We identified one silent exonic and seven intronic fixed-nucleotide differences between the human and chimpanzee SDHA genes (Additional file 2), corresponding to a substitution rate of 0.28%. The nucleotide substitution rate in SDHA is lower than the average of 127 known genes (0.75%) that were recently sequenced in human and chimpanzee [29]. The chimpanzee SDHA gene has 10 polymorphic variants, compared with 21 in the human gene in the same region, and showed ~2.9-fold lower nucleotide diversity (pi) than the human gene (Table 3). Furthermore, thetas and pi estimates of nucleotide diversities were similar in the chimpanzee, consistent with neutral expectations. These findings indicate that the mutation rate in SDHA is not inherently high and that the increased nucleotide diversity in the human gene must have occurred after the split of the two species from their common ancestor 5-6 million years ago.
###end p 20
###begin title 21
Tests of neutrality
###end title 21
###begin p 22
###xml 50 52 50 52 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D </italic>
###xml 76 79 76 79 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D* </italic>
###xml 83 86 83 86 <italic xmlns:xlink="http://www.w3.org/1999/xlink">F* </italic>
###xml 297 298 297 298 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T4">4</xref>
###xml 346 351 346 351 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SDHA </italic>
###xml 450 451 450 451 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T5">5</xref>
###xml 531 536 531 536 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SDHA </italic>
###xml 691 692 691 692 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S1">1</xref>
###xml 743 748 743 748 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SDHA </italic>
###xml 887 888 887 888 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T5">5</xref>
###xml 1033 1038 1033 1038 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SDHA </italic>
We employed three commonly used tests (the Tajima D tests and the Fu and Li D* and F* tests) to identify departures of the allelic distributions from neutral expectations. None of the PGL genes showed statistically significant departures from neutrality in samples from either racial group (Table 4). In contrast, the allelic distribution of the SDHA gene showed positive test values at statistically significant levels in both racial samples (Table 5). Notably, the neutrality statistics were supportive of balancing selection on SDHA despite the presence of six singleton variants in the African American samples and one singleton variant in the European American samples (Additional file 1). To obtain a clearer picture of the departure of SDHA allelic distributions from neutral expectations, we analyzed non-coding, coding, synonymous, and non-synonymous variants separately (Table 5). Nominally significant departures from neutrality were obtained in seven of the nine test statistics for the non-coding variants, although the SDHA coding region variation was also suggestive of an excess of variants in intermediate frequencies in the African American samples.
###end p 22
###begin p 23
###xml 49 54 49 54 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SDHA </italic>
###xml 365 367 365 367 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B30">30</xref>
###xml 377 379 377 379 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B31">31</xref>
###xml 394 396 394 396 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B32">32</xref>
###xml 447 449 444 446 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B33">33</xref>
###xml 572 577 569 574 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SDHA </italic>
###xml 621 622 618 619 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S3">3</xref>
###xml 656 661 653 658 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SDHA </italic>
###xml 809 811 806 808 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B34">34</xref>
###xml 944 949 941 946 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SDHA </italic>
###xml 1049 1054 1046 1051 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SDHA </italic>
###xml 1112 1114 1109 1111 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p </italic>
###xml 1124 1126 1121 1123 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-3</sup>
###xml 1134 1135 1131 1132 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T6">6</xref>
###xml 1222 1227 1219 1224 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SDHA </italic>
###xml 98 103 <span type="species:ncbi:9606">human</span>
###xml 108 118 <span type="species:ncbi:9598">chimpanzee</span>
To test whether the level of silent diversity in SDHA correlates with level of divergence between human and chimpanzee, as predicted by the neutral theory, we used the Hudson-Kreitman-Aguade (HKA) test. Sequence data from four loci that were assumed to be evolving neutrally were used for comparison. These loci include non-coding regions on chromosome bands 1q24 [30], 22q11 [31], and Xq13.3 [32] and the promoter region of beta-globin at 11p15 [33]. Locus-by-locus comparison provided statistical significance in two of the four tests, suggesting increased diversity in SDHA relative to these two loci (Additional file 3). To further address whether the SDHA variation pattern is unusual when information from the comparison loci is jointly used, we used a recently developed maximum-likelihood-ratio test [34]. The likelihood of two models were compared; the first assumes that all five loci evolve neutrally, whereas the other assumes that SDHA is subject to selection while the other four loci evolve neutrally. The model assuming selection on SDHA was statistically supported over the model of neutrality (p = 5.3 x 10-3; Table 6). These results further support the hypothesis that increased nucleotide diversity in SDHA is maintained by balancing selection.
###end p 23
###begin title 24
Empirical assessment of neutrality in SDH subunit genes
###end title 24
###begin p 25
###xml 275 277 275 277 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D </italic>
###xml 462 464 462 464 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D </italic>
###xml 561 566 561 566 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SDHC </italic>
###xml 570 575 570 575 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SDHD </italic>
###xml 627 632 627 632 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SDHA </italic>
###xml 682 684 682 684 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p </italic>
###xml 721 723 721 723 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D </italic>
###xml 762 764 762 764 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p </italic>
###xml 827 828 827 828 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2</xref>
###xml 844 849 844 849 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SDHB </italic>
###xml 911 913 911 913 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p </italic>
###xml 1030 1032 1030 1032 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D </italic>
###xml 1049 1053 1049 1053 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ABO </italic>
###xml 1060 1062 1060 1062 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D </italic>
###xml 1166 1168 1166 1168 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B35">35</xref>
###xml 1196 1198 1196 1198 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D </italic>
###xml 1201 1206 1201 1206 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SDHA </italic>
###xml 1239 1241 1239 1241 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D </italic>
###xml 1276 1280 1276 1280 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ABO </italic>
###xml 1294 1295 1294 1295 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2</xref>
###xml 1367 1372 1367 1372 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SDHA </italic>
###xml 1454 1459 1454 1459 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SDHA </italic>
Because population history plays an important role in shaping the variation patterns in the genome, we sought to assess whether the nucleotide diversity of complex II genes were unusual compared with other genes across the genome. We used the summary statistics for Tajima's D test and nucleotide diversity of 282 genes listed in the SeattleSNP database for comparison. When compared with the database genes, the statistics for nucleotide diversity and Tajima's D were not outstanding for any of the complex II genes in the European American samples or for the SDHC and SDHD genes in the African American samples. However, the SDHA nucleotide diversity was higher than that of 279 (p < 0.015) of the genes and the Tajima D statistic was higher than that of 281 (p < 0.0036) of the genes in the African American samples (Figure 2). In contrast, SDHB had less sequence diversity than 280 of the SeattleSNP genes (p < 0.011) in the African American samples. A recent analysis of 151 loci in the SeattleSNP set has indicated that the D statistic of the ABO locus (D = 1.58) retains its significance in an African American population under several demographic scenarios [35]. Because the magnitude of D in SDHA in our African American samples (D = 1.95) is higher than that in the ABO locus (Figure 2), it is likely that the statistical support for balancing selection on SDHA would be retained by different population histories. In summary, the departure of SDHA allelic distribution from neutral expectations is empirically supported in the African American samples, consistent with a balancing selection mechanism.
###end p 25
###begin title 26
Haplotype structures of the SDH subunit genes
###end title 26
###begin p 27
###xml 251 256 251 256 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SDHA </italic>
###xml 467 468 467 468 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S1">1</xref>
###xml 696 697 696 697 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S4">4</xref>
###xml 818 822 818 822 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SDHB</italic>
###xml 824 828 824 828 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SDHC</italic>
###xml 834 839 834 839 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SDHD </italic>
Haplotypes, haplotype-block structures and the tagging SNPs for each block were inferred using the web-based HAP software (see methods). As expected, the haplotypes were more variable in the African American than in the European American samples. The SDHA haplotype variation could be defined by 6 haplotype blocks and 13 tagging SNPs in the African American samples but only by 3 haplotype-blocks and 5 tagging SNPs in the European American samples (Additional file 1). In contrast, haplotype variation in the PGL genes could be defined by single-haplotype blocks. The most common haplotype accounted for ~99% of the haplotypes of the PGL genes in the European American samples (Additional file 4). Similarly, the most common haplotype and its 1-nucleotide neighbors covered ~98%, 79% and 73% of the variation in the SDHB, SDHC, and SDHD genes, respectively, in the African American samples.
###end p 27
###begin p 28
###xml 173 178 173 178 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SDHA </italic>
###xml 221 226 221 226 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SDHA </italic>
###xml 404 405 404 405 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3</xref>
###xml 892 903 892 903 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dirofilaria</italic>
###xml 713 722 <span type="species:ncbi:9600|species:ncbi:9601">orangutan</span>
###xml 733 738 <span type="species:ncbi:10090">mouse</span>
###xml 740 743 <span type="species:ncbi:9615">dog</span>
###xml 745 748 <span type="species:ncbi:10116">rat</span>
###xml 754 760 <span type="species:ncbi:9913">bovine</span>
###xml 857 866 <span type="species:ncbi:7955">zebrafish</span>
The commonness of a single haplotype and its 1-nucleotide neighbors in the PGL genes was in stark contrast to the presence of two common but highly dissimilar haplotypes in SDHA in both racial groups. The two most common SDHA haplotypes, A1 and A2, accounted for ~19% (17/90) and ~9% (8/90) of all haplotype diversity, respectively, and differed from each other in 22 of the 36 variant positions (Figure 3). Haplotype A1 and A2 encode the missense Fp variants Y629-V657 and F629-657, by the SNPs 27 and 35, respectively, indicating an allelic association of the missense variants in these two amino-acid sites. Notably, the variant Fp amino acids Y629 and V657 were conserved in mammalian Fp sequences, including orangutan, macaque, mouse, dog, rat, and bovine. However, different amino acids were found in phylogenetically more distant species such as the zebrafish, which had Y629-I657 and Dirofilaria, an infectious nematode, which had E629-I657.
###end p 28
###begin p 29
###xml 24 29 24 29 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SDHA </italic>
###xml 628 629 628 629 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4</xref>
All of the remaining 34 SDHA haplotypes were highly similar to one of the two commonest haplotypes, and formed two distinct haplotype sets, referred to as haplogroup 1 and haplogroup 2. The haplotypes within each group differed from the most common haplotype of the group in up to seven variant positions, with a median number of three differences. The frequencies of haplogroups 1 and 2 were ~56% and ~44% in the African American samples and ~82% and ~18% in the European American samples, respectively. A median-joining network of all haplotypes clustered all but one haplotype within two distinct haplogroup clusters (Figure 4). The only haplotype (RR) that mapped outside of the two haplogroups clusters was probably a recombination product between haplogroup 1 and haplogroup 2.
###end p 29
###begin title 30
Haplotype number test
###end title 30
###begin p 31
###xml 40 45 40 45 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SDHA </italic>
###xml 186 188 186 188 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B36">36</xref>
###xml 286 287 286 287 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3</xref>
###xml 539 544 539 544 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SDHA </italic>
To test whether the number of predicted SDHA haplotypes in the African American samples is compatible with neutral evolution, we employed the Depaulis and Veuille haplotype number test [36]. In total, 35 variants in 46 African American sequences defined 27 different haplotypes (Figure 3). Using Depaulis and Veuille simulations under assumptions of neutrality showed that when there are 40 variants in 50 sequences, the upper limit of the 95% confidence interval for the expected number of different haplotypes is 24. Thus, the number of SDHA haplotypes is statistically significantly higher than expected under neutrality, and is consistent with an ancient balanced polymorphism in the African American population.
###end p 31
###begin title 32
###xml 22 27 22 27 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SDHA </italic>
Estimating age of the SDHA haplogroups
###end title 32
###begin p 33
###xml 309 310 309 310 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3</xref>
###xml 602 607 602 607 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SDHA </italic>
###xml 116 121 <span type="species:ncbi:9606">human</span>
###xml 126 136 <span type="species:ncbi:9598">chimpanzee</span>
###xml 337 342 <span type="species:ncbi:9606">human</span>
###xml 347 357 <span type="species:ncbi:9598">chimpanzee</span>
###xml 573 578 <span type="species:ncbi:9606">human</span>
###xml 583 594 <span type="species:ncbi:9598">chimpanzees</span>
###xml 732 737 <span type="species:ncbi:9606">human</span>
###xml 742 753 <span type="species:ncbi:9598">chimpanzees</span>
We estimated the age of the two haplogroups by comparing the sequence divergence between them with that between the human and chimpanzee genes, assuming a constant evolutionary rate of nucleotide substitutions. Haplogroups 1 and 2 have eight fixed nucleotide differences, at SNPs 8-12, 17, 21, and 22 (Figure 3), within 5255 bp, whereas human and chimpanzee genes have eight fixed nucleotide differences within 2832 bps. On the basis of these fixed nucleotide substitutions, we estimated haplogroups 1 and 2 to be as old as [(8/5255)/(8/2832)] times the divergence time of human and chimpanzees. Thus, SDHA balanced polymorphisms were estimated to be 2.69-3.23 million years old, assuming a divergence time of 5-6 million years for human and chimpanzees. This is probably a conservative estimate, as the fixed differences between the haplogroups erode in time by recombination and gene conversion.
###end p 33
###begin title 34
Discussion
###end title 34
###begin p 35
###xml 244 249 244 249 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SDHA </italic>
###xml 647 652 647 652 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SDHA </italic>
Our results establish a foundation to understand the selective and demographic forces that have shaped the variation patterns in SDH subunit genes, and have important functional implications. Our findings indicate that the variation pattern in SDHA is characterized by the presence of higher sequence diversity, two common and highly dissimilar haplogroups, and statistical and empirical support for the operation of a balancing selection mechanism. Our data also refute the previous suggestions that the Y629F and V657I variants originate from two distinct genetic loci because these missense variants are encoded by a single, highly polymorphic SDHA gene.
###end p 35
###begin p 36
###xml 83 87 83 87 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SDHB</italic>
###xml 109 114 109 114 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SDHB </italic>
###xml 448 453 448 453 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SDHB </italic>
###xml 587 589 587 589 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B37">37</xref>
###xml 590 592 590 592 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B38">38</xref>
###xml 668 673 668 673 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SDHA </italic>
###xml 751 756 751 756 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SDHA </italic>
The PGL genes had much lower nucleotide diversity, which was especially evident in SDHB, suggesting that the SDHB gene product might be under functional constraints that preclude the accumulation of variants. If slightly deleterious variants in PGL genes increase the risk of paraganglioma tumor development, such variants would be eliminated before they reach high frequencies in the population. This potential mechanism might apply especially to SDHB because its mutations are associated with malignancy and early-onset pheochromocytomas that could lead to severe hypertensive crises [37,38]. In contrast, because there is no evidence that heterozygous mutations in SDHA are associated with a pathologic phenotype, negative selection of deleterious SDHA alleles may operate only when they are in the homozygous state, which often leads to a lethal metabolic syndrome in childhood.
###end p 36
###begin p 37
###xml 82 87 82 87 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SDHA </italic>
###xml 209 211 209 211 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B39">39</xref>
###xml 267 272 267 272 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SDHA </italic>
###xml 424 429 424 429 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SDHA </italic>
###xml 441 443 441 443 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B40">40</xref>
###xml 478 483 478 483 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SDHA </italic>
###xml 565 573 565 573 <italic xmlns:xlink="http://www.w3.org/1999/xlink">de novo </italic>
###xml 594 599 594 599 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SDHA </italic>
###xml 763 768 763 768 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SDHA </italic>
###xml 816 821 816 821 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SDHA </italic>
###xml 904 909 904 909 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SDHA </italic>
###xml 999 1004 999 1004 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SDHA </italic>
###xml 752 762 <span type="species:ncbi:9598">chimpanzee</span>
###xml 857 867 <span type="species:ncbi:9598">chimpanzee</span>
###xml 993 998 <span type="species:ncbi:9606">human</span>
###xml 1093 1098 <span type="species:ncbi:9606">human</span>
A major finding of our study is the unexpectedly high nucleotide diversity in the SDHA gene in the African American samples. It has been suggested that high local recombination rates may increase SNP density [39]. However, this mechanism is unlikely to contribute to SDHA variant density, because a recent high-resolution recombination map indicates a very low recombination rate at the tip of chromosome 5 short arm, where SDHA is located [40]. It is conceivable that the four SDHA pseudogenes, generated by complete or partial gene duplications, may increase the de novo mutation rate in the SDHA gene through illegitimate recombination or gene conversion during meiosis to increase variant density. However, lack of high nucleotide diversity in the chimpanzee SDHA gene does not suggest that the mutation rate in SDHA is inherently high, even though the chimpanzee genome also contains the duplicated SDHA pseudogenes. Rather, our findings suggest that the high nucleotide diversity of the human SDHA gene is a consequence of persistence of two distinct haplogroups for long periods during human evolution, leading to acquisition of a distinct set of polymorphisms by each haplogroup.
###end p 37
###begin p 38
###xml 120 124 120 124 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SDHA</italic>
###xml 228 230 228 230 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B41">41</xref>
###xml 536 539 536 539 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cis</italic>
###xml 561 565 561 565 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CCR5</italic>
###xml 612 614 612 614 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B42">42</xref>
###xml 661 663 661 663 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B43">43</xref>
###xml 701 705 701 705 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PTC </italic>
###xml 706 708 706 708 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B44">44</xref>
###xml 764 766 764 766 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D </italic>
###xml 794 798 794 798 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SDHA</italic>
###xml 824 828 824 828 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SDHA</italic>
###xml 874 876 874 876 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D </italic>
###xml 962 964 962 964 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D </italic>
###xml 1083 1085 1083 1085 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D </italic>
###xml 1265 1267 1265 1267 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D </italic>
###xml 1363 1365 1363 1365 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B35">35</xref>
###xml 1474 1476 1474 1476 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D </italic>
###xml 454 459 <span type="species:ncbi:9606">human</span>
###xml 605 610 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1219 1225 <span type="species:ncbi:9606">humans</span>
The most important finding of our study is the statistical and empirical support for a balancing selection mechanism on SDHA. A classic example of balancing selection is found at the major histocompatibility complex (MHC) loci [41], where high levels of polymorphisms in the functional MHC genes may confer a selective advantage to the heterozygotes by enabling them to process a wider range of pathogen antigens on T cells. The variation in a few other human genes may also have been shaped by balancing selection. For example, the 5' cis-regulatory region of CCR5, encoding the principal coreceptor for HIV-1 [42], protocadherin alpha gene cluster promoters [43] and the bitter-taste receptor gene, PTC [44], have two major ancient haplotype groups and positive D test statistics, similar to SDHA. However, in contrast to SDHA, these genes did not show significant Tajima D statistics in the African or African American samples. In general, the average Tajima D value is positive in the European American population and negative in the African American population. Positive Tajima D statistics in European Americans are often interpreted to reflect population contraction that occurred during the migration of modern humans out of Africa, whereas negative Tajima D statistics in African Americans may reflect admixture between African and European populations [35]. Thus, evidence of balancing selection on a gene, suggested by statistically significantly positive Tajima D values, is more likely to be confounded by population history in European American samples than in African American samples.
###end p 38
###begin p 39
###xml 126 131 126 131 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SDHA </italic>
###xml 394 405 394 405 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Arthrinium </italic>
###xml 763 765 763 765 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B45">45</xref>
###xml 1017 1019 1017 1019 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 1020 1022 1020 1022 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B46">46</xref>
###xml 1154 1159 1154 1159 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SDHA </italic>
###xml 1698 1703 1698 1703 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SDHA </italic>
###xml 783 788 <span type="species:ncbi:9606">human</span>
###xml 814 823 <span type="species:ncbi:128810|species:ncbi:4547">sugarcane</span>
###xml 876 881 <span type="species:ncbi:9606">human</span>
###xml 1752 1757 <span type="species:ncbi:9606">human</span>
It is conceivable that an environmental factor prevalent in Africa may have contributed to the increased frequency of certain SDHA variants that might have differential roles in the regulation of oxygen homeostasis by the SDH complex. A candidate environmental factor is the neurotoxin 3-NPA and its aliphatic nitrocompounds derivatives. In addition to being a product of certain fungi such as Arthrinium species, 3-NPA and its derivatives are also found in several higher plants. The toxicity of these plants is well established, because their aliphatic nitrocompound contents have been linked to acute and chronic diseases in some domestic animals. Major livestock losses were attributed to plant nitrocompounds in the western United States, Canada and Mexico [45]. Thus, although human toxicity involving moldy sugarcane poisoning have to date been reported only in China, human exposure to 3-NPA and other nitrocompounds might be more common throughout the world than is indicated by the numbe of clinical cases [18,46]. 3-NPA exposure might be more prevalent in Africa partly because a hot and humid climate promotes the growth of fungi. If certain SDHA variants confer a selective advantage against 3-NPA poisoning by affecting gene expression levels, protein translation efficiency, and/or the binding affinity for 3-NPA, then such variants may provide a survival advantage for their carriers against 3-NPA poisoning. Alternatively, SDH may play a currently unrecognized role against infectious pathogens such as malaria, which are prevalent in Africa. Genetic studies of PGL suggest that inactivation of SDH by subunit mutations inappropriately activates hypoxia-inducible pathways. If the SDHA variants that have increased in frequency during human evolution are hypomorphs or encode Fps that have slight functional deficits, these variants might promote the activation of hypoxia-inducible pathways and help the immune cells to survive better under sustained hypoxic microenvironments of the infected tissues.
###end p 39
###begin p 40
###xml 73 78 73 78 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SDHA </italic>
###xml 185 190 185 190 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SDHA </italic>
###xml 281 286 281 286 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SDHA </italic>
###xml 498 503 498 503 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SDHA </italic>
###xml 577 582 577 582 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SDHA </italic>
###xml 203 208 <span type="species:ncbi:9606">human</span>
Finally, our findings do not support the previous explanations as to why SDHA mutations are not associated with PGL susceptibility because these explanations assume the presence of two SDHA genes in the human genome. Instead, the contrasting patterns of sequence variation between SDHA and the PGL genes suggest the presence of two functionally distinct modules in SDH: one formed by the three closely-associated PGL gene products (PGL module), and the other a loosely-interacting, highly-variable SDHA protein product. This model provides an alternative explanation as to why SDHA mutations do not cause PGL and predicts the following two conditions:
###end p 40
###begin p 41
###xml 34 39 34 39 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SDHA </italic>
###xml 163 168 163 168 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SDHA </italic>
(i) The relative concentration of SDHA protein product is much higher (>two-fold) than the PGL module in the paraganglionic tissues. Thus, even a 50% reduction in SDHA protein levels, as a result of heterozygous mutations, would not compromise the SDH function in paraganglia to initiate tumor formation.
###end p 41
###begin p 42
###xml 42 47 42 47 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SDHA </italic>
###xml 144 149 144 149 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SDHA </italic>
(ii) The physical interaction between the SDHA protein product and the PGL module is loose and kinetically fast during catalysis, thus a mutant SDHA protein product could not irreversibly trap a PGL module to initiate tumor formation.
###end p 42
###begin title 43
Conclusion
###end title 43
###begin p 44
###xml 34 39 34 39 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SDHA </italic>
###xml 146 151 146 151 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SDHA </italic>
###xml 395 400 395 400 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SDHA </italic>
Our findings demonstrate that the SDHA gene carries a strong signature of balancing selection in the African American population and that PGL and SDHA gene products are subject to distinct selective constraints. Collectively, these data provide new insights into SDH biology and may catalyze further research on the causes and the consequences of the unexpectedly high sequence diversity in the SDHA subunit gene.
###end p 44
###begin title 45
Methods
###end title 45
###begin title 46
Samples
###end title 46
###begin p 47
###xml 470 475 470 475 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SDHA </italic>
###xml 654 659 654 659 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SDHA </italic>
###xml 700 715 700 715 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pan troglodytes</italic>
###xml 125 130 <span type="species:ncbi:9606">women</span>
###xml 203 208 <span type="species:ncbi:9606">Human</span>
###xml 687 698 <span type="species:ncbi:9598">chimpanzees</span>
###xml 700 715 <span type="species:ncbi:9598">Pan troglodytes</span>
###xml 784 789 <span type="species:ncbi:9606">Human</span>
DNA was isolated using standard protocols from samples from 24 unrelated African American and 24 unrelated European American women, which are part of an anonymized sample collection in the Department of Human Genetics at The University of Pittsburgh School of Public Health. The samples were collected under research protocols approved by the internal review board review committee. One African American and two European American samples that failed to amplify multiple SDHA exons on repeated attempts were removed from certain analyses, including minor allele frequency calculations, haplotype analysis, and neutrality statistics. We also sequenced the SDHA gene in 18 unrelated common chimpanzees (Pan troglodytes), which are part of the primate DNA collection in the Department of Human Genetics.
###end p 47
###begin title 48
PCR and sequencing
###end title 48
###begin p 49
###xml 272 273 272 273 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S5">5</xref>
###xml 317 321 317 321 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Taq </italic>
###xml 384 389 384 389 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SDHA </italic>
###xml 663 668 663 668 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SDHA </italic>
###xml 748 753 748 753 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SDHA </italic>
###xml 957 962 957 962 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SDHA </italic>
###xml 1150 1152 1150 1152 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 1170 1175 1170 1175 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SDHA </italic>
###xml 1431 1436 1431 1436 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SDHA </italic>
###xml 1481 1486 1481 1486 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SDHA </italic>
###xml 1582 1587 1582 1587 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SDHA </italic>
###xml 1783 1788 1783 1788 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SDHA </italic>
###xml 1852 1853 1852 1853 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S5">5</xref>
###xml 1891 1896 1891 1896 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SDHA </italic>
###xml 2166 2168 2166 2168 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B47">47</xref>
###xml 2290 2295 2290 2295 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SDHA </italic>
###xml 576 581 <span type="species:ncbi:9606">human</span>
###xml 883 888 <span type="species:ncbi:9606">human</span>
###xml 2106 2111 <span type="species:ncbi:9606">human</span>
PCR amplification for each exon was performed by using oligonucleotide primers that were designed from the flanking intronic or untranslated sequences of the exons. The primer sequences and the amplicon sizes for each SDH subunit gene exon are provided in Additional file 5. The PCR amplification was performed using Taq polymerase under standard conditions. The PCR amplification of SDHA is potentially confounded by the presence of multiple pseudogenes created by genomic duplications. These pseudogenes contain multiple mutations in their coding regions. BLAST analyses of human expressed sequences database in GenBank reveal no evidence for expression of the SDHA pseudogenes (data not shown). The PCR primers for specific amplification of the SDHA gene were designed so that the 3' ends of the primers were placed at nucleotides that showed divergence from the pseudogenes. The human genome March 2006 sequence assembly at UCSC database indicates that SDHA has two complete and one truncated gene duplications within ~3 Mb at chromosome band 3q29 and one truncated duplication ~100 kb centromeric to the functional gene at chromosome band 5p15 [24]. The duplicated SDHA copies have 92.5-98.4% sequence identity with the functional gene within the exons and in the flanking introns. This high degree of sequence identity has erroneously led to the designation of some of the fixed nucleotide differences between the functional SDHA gene and its pseudogenes as real SNPs in the SDHA gene in the dbSNP database. In our experiments, we confirmed the specific amplification of each SDHA exon by analyzing the nucleotide positions of the amplicons where there are fixed differences between the functional and the duplicated gene copies (number of fixed nucleotide differences between SDHA and its duplicated pseudogenes are indicated in Additional file 5). In addition, we confirmed that all SDHA exonic variants, except the rare variants of SNPs 15, 33, and 36, which were observed only once in our whole sample set (i.e. were singletons), are represented by multiple expressed sequence tags (ESTs) in the human EST database at NCBI as determined by BLAST analyses [47]. Taken together, these results confirm that our genomic primers have specifically amplified the exons of the functional SDHA gene while avoiding the duplicated pseudogenes.
###end p 49
###begin title 50
Computational analyses
###end title 50
###begin p 51
###xml 581 583 572 574 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B48">48</xref>
###xml 658 660 649 651 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B49">49</xref>
###xml 777 779 768 770 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B50">50</xref>
The sequenced segments of the genes, including the coding, non-coding and flanking intronic sequences, were conjoined in a single gene-sequence file. This file was then used to enter polymorphism data for each sample using Sequenchertrade mark software (Gene Codes Corporation, Ann Arbor, MI, USA). The sequence files for each sample were used to generate input files for data analyses in population genetic software. Nucleotide diversity, population diversification analyses and departures from Hardy-Weinberg expectations were calculated using Arlequin software (version 2.001) [48]. Tests of neutrality were conducted using DnaSp software (version 4.10) [49]. The phylogenic relationship between the inferred haplotypes was established using Network software (version 4.1) [50]. All software programs were operated on a PC platform. Haplotype analyses and the prediction of tagging SNPs were performed using HAP, a free web-based haplotype analysis software.
###end p 51
###begin title 52
Sequence databases
###end title 52
###begin p 53
###xml 121 126 121 126 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SDHA </italic>
###xml 148 150 148 150 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 308 310 308 310 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B51">51</xref>
###xml 437 439 437 439 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B52">52</xref>
We used the BLAT function of UCSC genome browser to determine the genomic locations of and sequence similarities between SDHA genomic duplications [24]. The Ensembl genome browser was used to determine the intron-exon junction, transcription initiation sites, and start/stop codons of the SDH subunit genes [51]. Gene variation data in the SeattleSNP database (August 2006) derived from 24 African American individuals and 23 Europeans [52] were used to compare with our results.
###end p 53
###begin title 54
Population genetics
###end title 54
###begin title 55
Nucleotide diversity
###end title 55
###begin p 56
###xml 193 194 188 189 <sub xmlns:xlink="http://www.w3.org/1999/xlink">s</sub>
###xml 350 352 341 343 <sub xmlns:xlink="http://www.w3.org/1999/xlink">s </sub>
###xml 356 357 347 348 <sub xmlns:xlink="http://www.w3.org/1999/xlink">e</sub>
###xml 368 370 358 360 <sub xmlns:xlink="http://www.w3.org/1999/xlink">e </sub>
Two measures of nucleotide diversity were derived using unphased genotypic data: pi, which measures the mean number of differences per nucleotide between two randomly chosen sequences and thetas, which measures the proportion of segregating sites under the assumption of an infinite site-neutral model. Both measures estimate the mutation rate, thetas = 4Nemu, where Ne is the effective population size and mu is the neutral mutation rate per generation.
###end p 56
###begin p 57
###xml 40 44 35 39 <sub xmlns:xlink="http://www.w3.org/1999/xlink">i&lt;j </sub>
###xml 46 50 40 44 <sub xmlns:xlink="http://www.w3.org/1999/xlink">i, j</sub>
###xml 52 53 46 47 <sub xmlns:xlink="http://www.w3.org/1999/xlink">c</sub>
###xml 63 68 56 61 <sub xmlns:xlink="http://www.w3.org/1999/xlink">i, j </sub>
###xml 116 117 109 110 <italic xmlns:xlink="http://www.w3.org/1999/xlink">i</italic>
###xml 124 125 117 118 <italic xmlns:xlink="http://www.w3.org/1999/xlink">j</italic>
###xml 147 149 140 142 <sub xmlns:xlink="http://www.w3.org/1999/xlink">c </sub>
In a sample of n chromosomes, pi = Sigmai<j pii, j/nc, where pii, j is the number of nucleotide differences between ith and jth DNA sequences and nc = n(n - 1)/2 and
###end p 57
###begin p 58
###xml 5 7 1 3 <sub xmlns:xlink="http://www.w3.org/1999/xlink">s </sub>
thetas = S/a, where 
###end p 58
###begin title 59
Tests of neutrality
###end title 59
###begin p 60
###xml 5 7 1 3 <sub xmlns:xlink="http://www.w3.org/1999/xlink">s </sub>
###xml 139 141 131 133 <sub xmlns:xlink="http://www.w3.org/1999/xlink">s </sub>
###xml 414 416 400 402 <sub xmlns:xlink="http://www.w3.org/1999/xlink">s </sub>
###xml 450 452 435 437 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B53">53</xref>
thetas is strongly affected by the existence of deleterious alleles, because such alleles are usually present in low frequencies, but thetas is not affected by the frequency of mutants. Conversely, pi is not significantly affected by the presence of rare deleterious alleles because pi incorporates the frequency of mutants. If some of the variants in the sample have selective effects, then the estimates of thetas and pi will be different. Tajima [53] used the difference between these two estimates to detect selection among the sequences.
###end p 60
###begin p 61
###xml 9 11 9 11 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D </italic>
###xml 38 40 38 40 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D </italic>
###xml 53 54 48 49 <sub xmlns:xlink="http://www.w3.org/1999/xlink">s</sub>
###xml 71 72 61 62 <sub xmlns:xlink="http://www.w3.org/1999/xlink">s</sub>
###xml 73 76 63 66 <sup xmlns:xlink="http://www.w3.org/1999/xlink">1/2</sup>
Tajima's D statistic is calculated as D = (pi - thetas)/[Var(pi - thetas]1/2
###end p 61
###begin p 62
###xml 13 15 13 15 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D </italic>
###xml 108 110 108 110 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D </italic>
###xml 200 202 200 202 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D </italic>
###xml 234 236 234 236 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D </italic>
###xml 285 287 285 287 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B54">54</xref>
The value of D is expected to be zero for selectively neutral variants in a constant population. A non-zero D value is a sign of departure from the neutral model caused by a relative excess (positive D values) or deficiency (negative D values) of substitutions of various frequencies [54].
###end p 62
###begin p 63
###xml 97 100 97 100 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D* </italic>
###xml 104 107 104 107 <italic xmlns:xlink="http://www.w3.org/1999/xlink">F* </italic>
###xml 124 126 124 126 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B55">55</xref>
###xml 288 291 288 291 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D* </italic>
###xml 295 298 295 298 <italic xmlns:xlink="http://www.w3.org/1999/xlink">F* </italic>
Departures from the neutral model of the allelic distributions can also be tested by Fu and Li's D* and F* test statistics [55]. These tests compare the number of mutations between internal and external branches of a sequence genealogy with their expectations under selective neutrality. D* and F* tests compare the number of nucleotide variants observed only once in a sample with the total number of nucleotide variants and with the mean pairwise difference between the sequences, respectively. We assessed the significance of neutrality test statistics by comparing the observed test values to those obtained by 10000 coalescent simulations using sample size and number of segregating sites as variables and assuming a standard neutral model with no recombination. Coalescent simulations were performed by DnaSp software (version 4.10).
###end p 63
###begin p 64
###xml 50 55 50 55 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SDHA </italic>
###xml 402 407 402 407 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SDHA </italic>
###xml 458 460 458 460 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B34">34</xref>
###xml 548 550 546 548 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2 </sup>
We used the HKA test for excesses of variation in SDHA gene. This test compares whether the level of intra-specific polymorphism parallels the level of nucleotide divergence between two species in a given locus relative to neutrally evolving loci. We used the direct HKA mode in the DNAsp software for locus-by-locus comparison. We also used a software testing maximum likelihood ratio of selection on SDHA in a multilocus framework as described previously [34]. Twice the difference of log likelihoods for two competing models is approximately chi2 distributed, with the degree of freedom (d.f.) equal to the number of selected loci. We seeded 100000 and 200000 cycles of the Markov chain to run two independent tests on a PC. Both chains provided similar results.
###end p 64
###begin title 65
Genetic structure of populations
###end title 65
###begin p 66
###xml 147 149 147 149 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B48">48</xref>
###xml 293 295 293 295 <sub xmlns:xlink="http://www.w3.org/1999/xlink">ST</sub>
The genetic structure of populations was investigated by the analysis of molecular variance (AMOVA) approach, as implemented in Arlequin software [48]. This approach is based on the analyses of variance of gene frequencies. The proportion of total variation among populations is estimated by FST, Wright's fixation index.
###end p 66
###begin title 67
Haplotype analyses
###end title 67
###begin p 68
###xml 111 113 111 113 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B56">56</xref>
###xml 577 579 577 579 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B50">50</xref>
We used HAP, a software employing a highly accurate method for common haplotype prediction from genotype data [56] to calculate minor allele frequencies of all variants. The haplotype resolution employs a phasing method that uses imperfect phylogeny. This method partitions the SNPs into haplotype blocks, and for each block, it predicts the common haplotypes and each individual's haplotype. We used Network (version 4.1), a phylogenetic network analysis software, to generate an evolutionary tree network that links the predicted haplotypes on the basis of their similarity [50].
###end p 68
###begin title 69
Authors' contributions
###end title 69
###begin p 70
BEB and REF conceived and designed the study. BEB performed the statistical analyses and drafted the manuscript. REF and ECL revised the manuscript critically for important intellectual content. ECL performed the sequence analyses. BEB and REF obtained funding. All authors read and approved the final manuscript.
###end p 70
###begin title 71
Supplementary Material
###end title 71
###begin title 72
Additional file 1
###end title 72
###begin p 73
Additional Table 1 - S DH subunit gene variants
###end p 73
###begin p 74
Click here for file
###end p 74
###begin title 75
Additional file 2
###end title 75
###begin p 76
###xml 75 79 75 79 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SDHA</italic>
###xml 64 74 <span type="species:ncbi:9598">chimpanzee</span>
Additional Table 2 - Sequence variants and fixed differences in chimpanzee SDHA
###end p 76
###begin p 77
Click here for file
###end p 77
###begin title 78
Additional file 3
###end title 78
###begin p 79
###xml 49 54 49 54 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SDHA </italic>
Additional Table 3 - Locus-by-locus HKA tests of SDHA versus neutrally evolving loci
###end p 79
###begin p 80
Click here for file
###end p 80
###begin title 81
Additional file 4
###end title 81
###begin p 82
###xml 45 49 45 49 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SDHB</italic>
###xml 51 55 51 55 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SDHC</italic>
###xml 61 65 61 65 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SDHD</italic>
Additional Table 4 - Haplotype structures of SDHB, SDHC, and SDHD
###end p 82
###begin p 83
Click here for file
###end p 83
###begin title 84
Additional file 5
###end title 84
###begin p 85
###xml 76 92 76 92 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SDHA, SDHB, SDHC</italic>
###xml 98 103 98 103 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SDHD </italic>
Additional Table 5 - PCR oligonucleotide primers and the amplicon sizes for SDHA, SDHB, SDHC, and SDHD exons
###end p 85
###begin p 86
Click here for file
###end p 86
###begin title 87
Acknowledgements
###end title 87
###begin p 88
We thank Joan W. Willett-Brozick for technical help and three reviewers for helpful suggestions. This research is supported in part by a National Institute of Health grant CA112364 to BEB.
###end p 88
###begin article-title 89
Molecular genetics of succinate:quinone oxidoreductase in eukaryotes
###end article-title 89
###begin article-title 90
Architecture of succinate dehydrogenase and reactive oxygen species generation
###end article-title 90
###begin article-title 91
Crystal structure of mitochondrial respiratory membrane protein complex II
###end article-title 91
###begin article-title 92
Mutations in SDHD, a mitochondrial complex II gene, in hereditary paraganglioma
###end article-title 92
###begin article-title 93
Mutations in SDHC cause autosomal dominant paraganglioma, type 3
###end article-title 93
###begin article-title 94
Gene mutations in the succinate dehydrogenase subunit sdhb cause susceptibility to familial pheochromocytoma and to familial paraganglioma
###end article-title 94
###begin article-title 95
###xml 64 72 <span type="species:ncbi:9606">patients</span>
Prevalence of SDHB, SDHC, and SDHD germline mutations in clinic patients with head and neck paragangliomas
###end article-title 95
###begin article-title 96
An Alu-mediated partial SDHC deletion causes familial and sporadic paraganglioma
###end article-title 96
###begin article-title 97
The SDH mutation database: an online resource for succinate dehydrogenase sequence variants involved in pheochromocytoma, paraganglioma and mitochondrial complex II deficiency
###end article-title 97
###begin article-title 98
Predictors and prevalence of paraganglioma syndrome associated with mutations of the SDHC gene
###end article-title 98
###begin article-title 99
A HIF1alpha regulatory loop links hypoxia and mitochondrial signals in pheochromocytomas
###end article-title 99
###begin article-title 100
Succinate links TCA cycle dysfunction to oncogenesis by inhibiting HIF-alpha prolyl hydroxylase
###end article-title 100
###begin article-title 101
The mitochondrial SDHD gene is required for early embryogenesis, and its partial deficiency results in persistent carotid body glomus cell activation with full responsiveness to hypoxia
###end article-title 101
###begin article-title 102
Altitude is a phenotypic modifier in hereditary paraganglioma type 1: evidence for an oxygen-sensing defect
###end article-title 102
###begin article-title 103
3-Nitropropionic acid's lethal triplet: cooperative pathways of neurodegeneration
###end article-title 103
###begin article-title 104
###xml 6 15 <span type="species:ncbi:128810|species:ncbi:4547">sugarcane</span>
Moldy sugarcane poisoning - a case report with a brief review
###end article-title 104
###begin article-title 105
3-Nitropropionic acid: a mitochondrial toxin to uncover physiopathological mechanisms underlying striatal degeneration in Huntington's disease
###end article-title 105
###begin article-title 106
###xml 63 68 <span type="species:ncbi:9606">human</span>
3-Nitropropionic acid-exogenous animal neurotoxin and possible human striatal toxin
###end article-title 106
###begin article-title 107
3-nitropropionic acid is a suicide inhibitor of mitochondrial respiration that, upon oxidation by complex II, forms a covalent adduct with a catalytic base arginine in the active site of the enzyme
###end article-title 107
###begin article-title 108
Mutation of a nuclear succinate dehydrogenase gene results in mitochondrial respiratory chain deficiency
###end article-title 108
###begin article-title 109
Phenotypic dichotomy in mitochondrial complex II genetic disorders
###end article-title 109
###begin article-title 110
###xml 66 71 <span type="species:ncbi:9606">human</span>
Direct evidence for expression of type II flavoprotein subunit in human complex II (succinate-ubiquinone reductase)
###end article-title 110
###begin article-title 111
###xml 70 75 <span type="species:ncbi:9606">human</span>
Direct evidence for two distinct forms of the flavoprotein subunit of human mitochondrial complex II (succinate-ubiquinone reductase)
###end article-title 111
###begin article-title 112
UCSC genome browser
###end article-title 112
###begin article-title 113
Mitochondrial succinate is instrumental for HIF1alpha nuclear translocation in SDHA-mutant fibroblasts under normoxic conditions
###end article-title 113
###begin article-title 114
SDH mutation database
###end article-title 114
###begin article-title 115
###xml 73 78 <span type="species:ncbi:9606">human</span>
Characterization of single-nucleotide polymorphisms in coding regions of human genes
###end article-title 115
###begin article-title 116
###xml 54 59 <span type="species:ncbi:9606">human</span>
Haplotype variation and linkage disequilibrium in 313 human genes
###end article-title 116
###begin article-title 117
###xml 27 32 <span type="species:ncbi:9606">human</span>
###xml 55 60 <span type="species:ncbi:9606">human</span>
Divergence of the genes on human chromosome 21 between human and other hominoids and variation of substitution rates among transcription units
###end article-title 117
###begin article-title 118
###xml 19 24 <span type="species:ncbi:9606">human</span>
Global patterns of human DNA sequence variation in a 10-kb region on chromosome 1
###end article-title 118
###begin article-title 119
###xml 70 75 <span type="species:ncbi:9606">human</span>
Worldwide DNA sequence variation in a 10-kilobase noncoding region on human chromosome 22
###end article-title 119
###begin article-title 120
###xml 74 79 <span type="species:ncbi:9606">human</span>
DNA sequence variation in a non-coding region of low recombination on the human X chromosome
###end article-title 120
###begin article-title 121
Polymorphism and divergence in the beta-globin replication origin initiation region
###end article-title 121
###begin article-title 122
The HKA test revisited: a maximum-likelihood-ratio test of the standard neutral model
###end article-title 122
###begin article-title 123
###xml 57 62 <span type="species:ncbi:9606">human</span>
Disentangling the effects of demography and selection in human history
###end article-title 123
###begin article-title 124
Neutrality tests based on the distribution of haplotypes under an infinite-site model
###end article-title 124
###begin article-title 125
Familial malignant catecholamine-secreting paraganglioma with prolonged survival associated with mutation in the succinate dehydrogenase B gene
###end article-title 125
###begin article-title 126
Mutations in the SDHB gene are associated with extra-adrenal and/or malignant phaeochromocytomas
###end article-title 126
###begin article-title 127
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human SNP variability and mutation rate are higher in regions of high recombination
###end article-title 127
###begin article-title 128
###xml 64 69 <span type="species:ncbi:9606">human</span>
A fine-scale map of recombination rates and hotspots across the human genome
###end article-title 128
###begin article-title 129
Pattern of nucleotide substitution at major histocompatibility complex class I loci reveals overdominant selection
###end article-title 129
###begin article-title 130
A strong signature of balancing selection in the 5' cis-regulatory region of CCR5
###end article-title 130
###begin article-title 131
###xml 110 115 <span type="species:ncbi:9606">human</span>
Extensive linkage disequilibrium, a common 16.7-kilobase deletion, and evidence of balancing selection in the human protocadherin alpha cluster
###end article-title 131
###begin article-title 132
Natural selection and molecular evolution in PTC, a bitter-taste receptor gene
###end article-title 132
###begin article-title 133
Toxicity and metabolism of the conjugates of 3-nitropropanol and 3-nitropropionic acid in forages poisonous to livestock
###end article-title 133
###begin article-title 134
###xml 42 47 <span type="species:ncbi:9606">human</span>
Contamination of food with mycotoxins and human health
###end article-title 134
###begin article-title 135
Basic Local Alignment Search Tool (BLAST)
###end article-title 135
###begin article-title 136
Arlequin: A software for population genetics data analysis
###end article-title 136
###begin article-title 137
DnaSP, DNA polymorphism analyses by the coalescent and other methods
###end article-title 137
###begin article-title 138
Median-joining networks for inferring intraspecific phylogenies
###end article-title 138
###begin article-title 139
Ensembl genome browser
###end article-title 139
###begin article-title 140
SeattleSNP database
###end article-title 140
###begin article-title 141
Statistical method for testing the neutral mutation hypothesis by DNA polymorphism
###end article-title 141
###begin article-title 142
###xml 39 44 <span type="species:ncbi:9606">human</span>
Signatures of natural selection in the human genome
###end article-title 142
###begin article-title 143
Statistical tests of neutrality of mutations
###end article-title 143
###begin article-title 144
Haplotype reconstruction from genotype data using Imperfect Phylogeny
###end article-title 144
###begin title 145
Figures and Tables
###end title 145
###begin p 146
###xml 0 89 0 89 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Minor allele frequency of each SDH subunit variant (also see Additional Table 1) is shown</bold>
Minor allele frequency of each SDH subunit variant (also see Additional Table 1) is shown. Filled vertical bars refer to African American, unfilled vertical bars refer to European American samples. Synonymous and non-synonymous coding variants are marked by S and NS, respectively. ID refers to insertion/deletion polymorphisms.
###end p 146
###begin p 147
###xml 9 11 9 11 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D </italic>
###xml 49 54 49 54 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SDHA </italic>
###xml 58 63 58 63 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SDHB </italic>
###xml 0 172 0 172 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Tajima's <italic>D </italic>statistic and nucleotide diversity in <italic>SDHA </italic>and <italic>SDHB </italic>genes (squares) relative to the 282 genes in SeattleSNP database are shown in the African American population</bold>
###xml 216 220 216 220 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ABO </italic>
###xml 224 228 224 228 <italic xmlns:xlink="http://www.w3.org/1999/xlink">FUT2</italic>
Tajima's D statistic and nucleotide diversity in SDHA and SDHB genes (squares) relative to the 282 genes in SeattleSNP database are shown in the African American population. Positions of two highly polymorphic loci, ABO and FUT2, the latter of which encodes the alpha(1,2)fucosyltransferase, are shown.
###end p 147
###begin p 148
###xml 14 18 14 18 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SDHA</italic>
###xml 0 18 0 18 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Haplotypes of <italic>SDHA</italic></bold>
Haplotypes of SDHA. Periods denote the identical SNP variant when compared to the most common haplotype of each haplogroup. @NC = non-coding, S = synonymous coding, NS = non-synonymous coding. I = insertion allele, D = deletion allele.  AA = African-American samples, EA = European-American samples.
###end p 148
###begin p 149
###xml 36 41 36 41 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SDHA </italic>
###xml 0 111 0 111 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A median-joining network groups all <italic>SDHA </italic>haplotypes (Figure 3) on the basis of number of nucleotide differences</bold>
A median-joining network groups all SDHA haplotypes (Figure 3) on the basis of number of nucleotide differences. The haplotype RR is probably a recombinant between the two haplogroups. The pie chart for each haplotype depicts the proportional contribution of the African American (filled portion) and the European American (unfilled portion) samples.
###end p 149
###begin p 150
Summary of variants in SDH subunit genes
###end p 150
###begin p 151
Sequence diversity in succinate dehydrogenase subunit genes
###end p 151
###begin p 152
AA, African American samples; EA, European American samples; SD, standard deviation.
###end p 152
###begin p 153
*Includes coding and non-coding sequences.
###end p 153
###begin p 154
daggerNumber of unrelated subjects.
###end p 154
###begin p 155
double daggerNumber of segregating sites.
###end p 155
###begin p 156
###xml 12 14 1 3 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p </italic>
section signp value for population genetic structure between AA and EA.
###end p 156
###begin p 157
###xml 47 52 47 52 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SDHA </italic>
###xml 26 31 <span type="species:ncbi:9606">human</span>
###xml 36 46 <span type="species:ncbi:9598">chimpanzee</span>
Sequence diversity in the human and chimpanzee SDHA genes
###end p 157
###begin p 158
AA, African American samples; EA, European American samples; SD, standard deviation.
###end p 158
###begin p 159
*Number of segregating sites.
###end p 159
###begin p 160
Tests of Neutrality in PGL genes
###end p 160
###begin p 161
AA, African American samples; EA, European American samples; SD, standard deviation.
###end p 161
###begin p 162
###xml 12 14 12 14 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p </italic>
###xml 49 53 49 53 <bold xmlns:xlink="http://www.w3.org/1999/xlink">bold</bold>
Significant p values (within parentheses) are in bold.
###end p 162
###begin p 163
*Includes coding and non-coding sequences.
###end p 163
###begin p 164
daggerNumber of unrelated subjects.
###end p 164
###begin p 165
###xml 136 140 124 128 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SDHC</italic>
double daggerNumber of segregating sites. DnaSp software excludes from the analyses the insertion/deletion variants, one of which is in SDHC.
###end p 165
###begin p 166
###xml 23 27 23 27 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SDHA</italic>
Tests of neutrality in SDHA
###end p 166
###begin p 167
AA, African American samples; EA, European American samples; SD, standard deviation.
###end p 167
###begin p 168
###xml 12 14 12 14 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p </italic>
###xml 49 53 49 53 <bold xmlns:xlink="http://www.w3.org/1999/xlink">bold</bold>
Significant p values (within parentheses) are in bold.
###end p 168
###begin p 169
*Number of unrelated subjects.
###end p 169
###begin p 170
###xml 155 160 150 155 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SDHA </italic>
###xml 187 192 182 187 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SDHA </italic>
###xml 240 245 235 240 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SDHA </italic>
###xml 277 279 272 274 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p </italic>
daggerNumber of segregating sites. DnaSp software excludes from the analyses the insertion/deletion variants, two of which were detected in the non-coding SDHA sequence. Inclusion of the SDHA indels, by recoding them as SNPs, increased all SDHA test statistics and reduced the p values (data not shown)
###end p 170
###begin p 171
###xml 59 64 59 64 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SDHA </italic>
Maximum-likelihood HKA analysis of silent polymorphisms in SDHA relative to four other neutrally evolving loci
###end p 171
###begin p 172
*Relative measure of diversity.
###end p 172

